HER2 Support Group Forums

HER2 Support Group Forums (https://her2support.org/vbulletin/index.php)
-   her2group (https://her2support.org/vbulletin/forumdisplay.php?f=28)
-   -   Oncotype DX now covered by UHC.. (https://her2support.org/vbulletin/showthread.php?t=26687)

Kimberly Lewis 01-12-2007 06:55 AM

Oncotype DX now covered by UHC..
 
<table id="article_tbl" align="left" border="0" cellpadding="0" cellspacing="0" width="970"><tbody><tr><td class="left_col" width="600"> UnitedHealth to cover cancer-recurrence tests

Minneapolis/St. Paul Business Journal - 12:54 PM CST Wednesday
by Carissa Wyant
Staff Writer


<!-- Article Tools --> United Healthcare Insurance Co. said Wednesday that it will offer coverage of a test for breast cancer recurrence.

Genomic Health Inc., which makes gene-based cancer tests, entered into an agreement with the affiliate of Minnetonka-based health insurer UnitedHealth Group. The new deal establishes coverage across all of UnitedHealthcare's plans for women with early-stage breast cancer. Coverage will become effective for claims for services performed on or after Jan. 3.

<table id="article_island_ad" align="left" border="0" cellpadding="0" cellspacing="0"> <tbody><tr> <td> <!-- 336 x 280 Ad --> <script language="JavaScript1.1" type="text/javascript" src="http://dc.bizjournals.com/js.ng/site=bizj&market=twincities&is_story=1&affiliate=t wincities&pos=c1&svs=health_care__physician_practi ces&transactionid=1168609173.253448.2179&tile=3977 2083815?"> </script><iframe src="http://view.atdmt.com/HBO/iview/bzjrmlib0110000003hbo/direct/01?click=" marginheight="0" marginwidth="0" topmargin="0" leftmargin="0" allowtransparency="true" frameborder="0" height="250" scrolling="no" width="300"> &lt;a href="http://clk.atdmt.com/HBO/go/bzjrmlib0110000003hbo/direct/01/" target="_blank"&gt;&lt;img src="http://view.atdmt.com/HBO/view/bzjrmlib0110000003hbo/direct/01/"/&gt;&lt;/a&gt;&lt;noscript&gt;&lt;a href="http://clk.atdmt.com/HBO/go/bzjrmlib0110000003hbo/direct/01/" target="_blank"&gt;&lt;img border="0" src="http://view.atdmt.com/HBO/view/bzjrmlib0110000003hbo/direct/01/" /&gt;&lt;/a&gt;&lt;/noscript&gt;</iframe> </td></tr></tbody></table> Oncotype DX quantifies the likelihood of breast cancer recurrence and predicts the likelihood of chemotherapy benefit for a large portion of early-stage breast cancer patients, Genomic Health said.

Contracts in place for Oncotype DX cover over 98 million people.

cwyant@bizjournals.com | (612) 288-2108



<!-- Send us your comments & More Latest News Buttons --> Contact the Editor Need Assistance? More Latest News http://ll.bizjournals.com/rd/redarrow.gif

Subscribe or renew online

<!-- Extra Special --> Extra

http://ll.bizjournals.com/specials/p...6/image_23.jpgWhat top jobs pay

How salaries for 20 key professions vary across the nation


<table id="related_tbl" align="left" border="0" cellpadding="0" cellspacing="0"> <tbody><tr> <td class="left_related_col" width="280">
</td><td class="right_related_col">
</td></tr><tr><td colspan="2">
</td></tr></tbody></table>
</td><td class="right_col">
</td></tr></tbody></table>


All times are GMT -7. The time now is 03:29 AM.

Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2026, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021